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RECEIVED 
SEP 13 2017 
INITIATIVE COORDINATOR 
ATTORNEY GENERAL'S OFFICE
By Hand Delivery 
September 8, 2017 
To: The Office of the Attorney General 
Attn: Ashley Johansson, Initiative Coordinator 
1300 "I" Street 
Sacramento, CA 95814 
Re: Submission of Amendment to the 
Kidney Dialysis Patient Protection Act (No. 17~0015) 
Dear Ms. Johansson: 
On August 9, 201 7 the proponents of a proposed statewide initiative titled "Kidney 
Dialysis Patient Protection Act" (the "Initiative") submitted a request that the Attorney General 
prepare a circulating title and summary pursuant to Article II, Section 10( d) of the California 
Constitution. Pursuant to Elections Code §9002(b ), the proponents hereby submit timely 
amendments to the text of the Initiative. As the proponents of the Initiative, we approve the 
submission of the amended text to the Initiative and we declare that the amendments are 
reasonably germane to the theme, purpose, and subject of the Initiative. We request that the 
Attorney General prepare a circulating title and summary using the amended Initiative. 
Please continue to direct all inquiries and correspondence regarding this proposed 
initiative to: 
BJ Chisholm 
Altshuler Berzon LLP 
177 Post Street, Suite 300 
San Francisco, CA 94108 
Phone: 415-421-7151 
Email: bchisholm@altber.com 
~n "~ I J!. ·  /
~enThcey V 
Enclosure: Amended initiative language 
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This initiative measure is submitted to the people in accordance with the provisions of 
Article II, Section 8, of the California Constitution. 
This initiative measure amends and adds sections to the Health and Safety Code; 
therefore, existing provisions proposed to be deleted are printed in strikeout type and new 
provisions proposed to be added are printed in italic type to indicate that they are new. 
SEC.l. Name 
This act shall be known as the "Kidney Dialysis Patient Protection Act." 
SEC. 2. Findings and Purposes 
A. The People make the following findings: 
(1) Kidney dialysis is a process where blood is cleaned of waste and excess water, 
usually through a machine outside the patient's body, and then returned to the patient. If 
someone who needs dialysis cannot obtain or afford high quality care, toxins build up in the 
body, leading to death. 
(2) In California, at least 66,000 Californians undergo dialysis treatment. 
(3) Just two multinational, for-profit corporations operate or manage nearly three­
quarters of dialysis clinics in California and treat almost 70 percent of dialysis patients in 
California. These two multinational corporations annually earn billions of dollars from their 
dialysis operations, including almost $400 million each year in California alone. 
(4) Because federal law mandates that private health insurance companies offer and pay 
for dialysis, private insurance companies have little ability to bargain with the two multinational 
dialysis corporations on behalf of their customers. 
(5) Thus, for-profit dialysis corporations charge patients with private health insurance 
four times as much as they charge Medicare for the very same dialysis treatment, resulting in 
vast profits. 
(6) In a market dominated by just two multinational corporations, California must ensure 
that dialysis is fairly priced and affordable. 
(7) Other states have taken steps to protect these very vulnerable patients from these two 
multinational corporations, including by enacting common sense protections such as minimum 
staffing requirements. 
(8) Current staffing levels in dialysis clinics in California are possibly dangerous and are 
inadequate to protect patient health against avoidable deaths, hospitalizations, infections, and 
medication errors. 
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(9) Efforts to enact protections for kidney dialysis patients in California have been 
stymied in Sacramento by the dialysis corporations, which spent over $600,000 in just the first 
six months of 2017 to influence the California Legislature. 
B. Purposes: 
(1) It is the purpose of this Act to ensure that outpatient kidney dialysis clinics provide 
quality and affordable patient care to people suffering from end stage renal disease. 
(2) This Act is intended to be budget neutral for the State to implement and administer. 
SEC. 3. Section 1226.4 is added to the Health and Safety Code, to read: 
1226. 4 (a) Minimum staffing requirements. 
(1) A chronic dialysis clinic shall ensure that the following minimum staffing ratios are met at 
all times that patients are receiving, or preparing to receive, direct clinic care: 
(A) At least one nurse is providing direct clinic care for every eight patients. A nurse shall only 
count toward this ratio during time periods the nurse has no responsibilities other than direct 
clinic care. A nurse manager or charge nurse shall not count toward the nurse-to-patient ratio. 
(B) At least one hemodialysis technician is providing direct clinic care for every three patients. 
A hemodialysis technician shall only count toward this ratio during time periods the 
hemodialysis technician has no responsibilities other than direct clinic care. Hemodialysis 
technician trainees shall not count toward this ratio. Nurses counted toward the nurse-to-patient 
ratio shall not count toward the hemodialysis technician-to-patient ratio. 
(2) A chronic dialysis clinic shall ensure that no more than 75 patients per full-time equivalent 
schedule are assigned at any time to any individual social worker and to any individual 
registered dietitian, regardless ofthe location where patient care is provided. 
(3) The ratios described in paragraphs (1) and (2) shall constitute the minimum number of 
nurses, hemodialysis technicians, social workers, and registered dietitians assigned to patients. 
Additional nurses, hemodialysis technicians, social workers, and registered dietitians shall be 
assigned to the extent necessary to ensure that the staff-to-patient ratio is appropriate to the 
level ofdialysis care given and meets the needs ofpatients. 
(4) A chronic dialysis clinic shall ensure that the transition time between patients at a treatment 
station is no shorter than 45 minutes, provided that the department may by regulation set a 
minimum transition time other than 45 minutes ifsuch modification is supported by changes in 
available clinical evidence regarding minimum transition times necessary to ensure safety and 
hygiene protocols in chronic dialysis clinics, including but not limited to changes in 
recommendations from the Centers for Disease Control and Prevention regarding standard 
hygiene practices. 
(5) The requirements ofthis subdivision shall take effect on March 31, 2019. 
(b) Inspections for safety and hygiene. 
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The department shall inspect each chronic dialysis clinic for which a license has been issued at 
least once per year, and shall conduct such inspections as often as necessary to ensure the 
existence ofand compliance with adequate hygiene and sanitation protocols, compliance with 
this chapter, and the adequacy ofthe quality ofcare being provided. 
(c) Licensing, recordkeeping, and reporting. 
(1) It shall be a condition oflicensure that a chronic dialysis clinic comply with this section, and 
the department shall not renew, transfer, or extend any license issued to a chronic dialysis clinic 
except upon a showing that the chronic dialysis clinic complies with the requirements of 
subdivision (a). The department shall not issue a license to any new chronic dialysis clinic unless 
that chronic dialysis clinic demonstrates the ability and intention to comply with the 
requirements ofsubdivision (a). 
(2) Every chronic dialysis clinic for which a license has been issued shall maintain, andprovide 
to the department on a form prescribed by the department, at a minimum, the following 
information: 
(A) Actual staffing ratio and transition time data for the period covered by the submission, 
which shall include, at a minimum, daily totals ofthe total number and actual hours worked by 
nurses and hemodialysis technicians; the total number ofpatients and actual hours receiving 
direct clinic care; the daily average transition time for each treatment station; and, for each 
week, the total number offull-time equivalent social workers and registered dietitians and the 
total number ofpatients assigned to social workers and registered dietitians. 
(B) Every instance, no matter how brief during the period covered by the submission when 
staffing ratios or transition times did not satisfy the requirements ofsubdivision (a), and the 
reasons and circumstances therefor. 
(3) The chiefexecutive officer or administrator ofthe chronic dialysis clinic shall certify under 
penalty ofperjury that he or she is satisfied, after review, that all information submitted pursuant 
to paragraph (2) is accurate and complete. 
(4) The chronic dialysis clinic shall periodically submit such information described in 
paragraph (2) to the department on a schedule and in a format prescribed by the department, 
provided that the clinic shall submit that information no less frequently than four times per year. 
(d) Complaints andpatient rights. 
(1) Within 60 days ofreceiving a complaint from a patient, an association ofpatients, a family 
member ofa patient, an employee, an association ofemployees, a vendor, or a contractor ofa 
chronic dialysis clinic that the chronic dialysis clinic has violated any requirement ofthis 
chapter, the department shall investigate the chronic dialysis clinic and, ifthe evidence shows a 
violation has occurred, the department shall impose discipline pursuant to Section 1240.1. 
(2) To ensure that all health care workers ofchronic dialysis clinics are entitled to 
whistleblower protections, Section 1278.5 shall apply to chronic dialysis clinics, and to the 
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extent ofthat application, references in Section 12 7 8. 5 to a health facility shall be deemed to be 
references to a chronic dialysis clinic, subject to paragraph (3). 
(3) Notwithstanding Section 1417.2, moneys collected under paragraph (3) ofsubdivision (b) of 
Section 1278.5 from a chronic dialysis clinic shall be distributed to the department to implement 
and enforce laws governing chronic dialysis clinics. 
(e) Protection ofconfidential information. 
(1) The department shall redact from any writing, record, or document submitted or created 
pursuant to this section that is a public record within the meaning ofsubdivision (e) ofSection 
6252 ofthe Government Code all personal identifying or confidential information associated 
with any patients, to the extent required to prevent an unwarranted invasion ofpersonal privacy, 
as that term is used in subdivision (c) ofSection 6254 ofthe Government Code, but the 
department shall not withhold any such writing, record, or document in its entirety under 
subdivision (c) ofSection 6254 ofthe Government Code. 
(2) Information required to be submitted under subdivision (c), and complaints submitted under 
subdivision (d), shall not be withheld on the basis ofsubdivision (I) ofSection 6254 ofthe 
Government Code. 
(I) Definitions. 
For purposes ofthis section: 
(1) "Administrator" means the administrator as that term is used in Section 494. l 80(a) a/Title 
42 ofthe Code ofFederal Regulations as it read on December 31, 2016. 
(2) "At all times" includes times during which clinic personnel, including but not limited to 
nurses or hemodialysis technicians, are provided meal periods and rest or other breaks. No 
clinic personnel may be counted toward the required ratios during times they are taking such 
breaks or meal periods. 
(3) "Charge nurse" means a charge nurse as described in Section 494.140(b)(3) ofTitle 42 of 
the Code ofFederal Regulations as it read on December 31, 2016. 
(4) "Chiefexecutive officer" means the chiefexecutive officer as that term is used in Section 
494.180(a) a/Title 42 ofthe Code ofFederal Regulations as it read on December 31, 2016. 
(5) "Direct clinic care" means initiating and discontinuing dialysis, monitoring patients during 
treatment, and administering medications, andphysical presence in the immediate area where 
patients are dialyzed. 
(6) "Full-time equivalent" means employment by a chronic dialysis clinic for 2,080 hours of 
work in 12 consecutive months. 
(7) "Nurse" means a registered nurse licensed pursuant to Chapter 6 (commencing with Section 
2700) ofDivision 2 ofthe Business and Professions Code. 
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(8) "Nurse manager" means a nurse manager as described in Section 494.140(b)(l) ofTitle 42 
ofthe Code ofFederal Regulations as it read on December 31, 2016. 
(9) "Registered dietitian" means a dietitian as described in Section 494.140(c) ofTitle 42 ofthe 
Code ofFederal Regulations as it read on December 31, 2016. 
(10) "Social worker" means a social worker as described in Section 494.140(d) ofTitle 42 of 
the Code ofFederal Regulations as it read on December 31, 2016. 
(11) "Hemodialysis technician" means a person who holds both ofthe following qualifications: 
(A) The person is a patient care dialysis technician, as described in Section 494.140(e) ofTitle 
42 ofthe Code ofFederal Regulations as it read on December 31, 2016. 
(B) The person is a Certified Hemodialysis Technician certified pursuant to Article 3. 5 
(commencing with Section 1247) ofChapter 3 ofDivision 2 ofthe Business and Professions 
Code. 
(12) "Hemodialysis technician trainee" means a person who is undergoing training to become a 
hemodialysis technician, but who has not yet been certified as a Certified Hemodialysis 
Technician pursuant to Article 3.5 (commencing with Section 1247) ofChapter 3 ofDivision 2 of 
the Business and Professions Code. 
(13) "Transition time " means the period oftime beginning when one patient leaves a treatment 
station and ending when the next patient is placed in the treatment station, but does not mean the 
period oftime after the last patient ofthe day leaves the treatment station. 
(14) "Treatment station " means a physical location within a chronic dialysis clinic where an 
individual patient is dialyzed. 
SEC. 4. Section 1240.1 is added to the Health and Safety Code, to read: 
1240.1 (a) The department may assess an administrative penalty against a chronic dialysis 
clinic for a violation ofthis chapter. Each penalty issued pursuant to this chapter shall be 
classified as a major violation, an intermediate violation, or a minor violation based on the 
nature ofthe violation and the threat ofharm to patients. A major violation shall be subject to an 
administrative penalty ofup to one hundred thousand dollars ($100,000), an intermediate 
violation shall be subject to an administrative penalty ofup to twenty thousand dollars 
($20, 000), and a minor violation shall be subject to an administrative penalty ofup to two 
thousand dollars ($2,000). 
(b) The department shall promulgate regulations establishing the criteria to assess an 
administrative penalty against a chronic dialysis clinic, which shall include, but not be limited 
to, consideration ofall ofthe following: 
(1) The probability and severity ofthe risk that the violation presents to the patient. 
(2) The actual harm to patients, ifany. 
(3) The nature, scope, and severity ofthe violation. 
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(4) The chronic dialysis clinic's history ofcompliance with related state andfederal statutes and 
regulations, including, but not limited to, the similarity in circumstances ofthe violation to any 
previous violation by the chronic dialysis clinic within a 24-month period. 
(5) Factors beyond the control ofthe chronic dialysis clinic that restrict its ability to comply 
with this chapter or the rules and regulations promulgated thereunder. 
(6) The demonstrated willfulness ofthe violation. 
(7) The extent to which the chronic dialysis clinic detected the violation and took immediate 
action to correct the violation and to prevent that type ofviolation from recurring. 
(c) Ifa chronic dialysis clinic disputes a determination by the department regarding an alleged 
deficiency or failure to correct a deficiency, or the reasonableness ofa proposed deadline for 
correction ofa violation or an amount ofan administrative penalty, the chronic dialysis clinic 
may, within 10 working days, request a hearing pursuant to Section 131071. A chronic dialysis 
clinic shall pay all administrative penalties when all appeals have been exhausted and the 
department's position has been upheld. 
(d) For purposes ofArticle 9 (commencing with Section 12650) ofChapter 6 ofPart 2 of 
Division 3 ofTitle 2 ofthe Government Code, the information required to be provided under 
subdivision (c) ofSection 1226.4 shall be deemed material to any claim for payment submitted 
by a chronic dialysis clinic within twelve months ofthe submission ofinformation. 
SEC. 5. Section 1240.2 is added to the Health and Safety Code, to read: 
1240.2. (a) Subject to subdivision (d), prior to the effective date ofregulations adopted to 
implement Section 1240.1, ifa chronic dialysis clinic receives a notice ofdeficiency constituting 
an immediate jeopardy to the health or safety ofa patient and is required to submit a plan of 
correction, the department may assess the licensee an administrative penalty ofup to one 
hundred thousand dollars ($100,000). In determining the amount ofthe penalty, the department 
shall consider the severity and duration ofthe immediate jeopardy and the extent to which the 
conduct causing the immediate jeopardy could have been avoided. 
(b) Ifa licensee disputes a determination by the department regarding an alleged deficiency or 
the alleged failure to correct a deficiency, or regarding the reasonableness ofthe proposed 
deadline for correction or the amount ofthe penalty, the licensee may, within 10 days, request an 
administrative hearing pursuant to Section 131071. Penalties shall be paid when appeals have 
been exhausted and ifthe department's position has been upheld. 
(c) For purposes ofthis section "immediate jeopardy" means a situation in which the licensee's 
noncompliance with one or more requirements oflicensure has caused, or is likely to cause, 
serious injury or death to one or more patients. 
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(d) This section shall only apply to incidents occurring on or after January 1, 2019, except that 
this section shall only apply to violations ofsubdivision (a) ofSection 1226.4 occurring on or 
after March 31, 2019. 
(e) Notwithstanding Section 11 ofthe act that added this section, new regulations are not 
required or authorized for implementation ofthis section. 
(f) This section shall become inoperative on the effective date ofregulations promulgated by the 
department pursuant to Section 1240.1. 
SEC. 6. Section 1226. 7 is added to the Health and Safety Code, to read: 
1226. 7. (a) Reasonable limits on charges for patient care by chronic dialysis clinics; rebates of 
amounts charged in excess offair treatment payment amount. 
(1) For purposes ofthis section, the "fair treatment payment amount" shall be an amount equal 
to 115 percent ofthe sum ofall direct patient care services costs and all health care quality 
improvement costs incurred by a governing entity and its chronic dialysis clinics. 
(2) For each fiscal year starting on or after January 1, 2019, a governing entity or its chronic 
dialysis clinics shall annually issue rebates to payers as follows: 
(A) The governing entity shall calculate the "unfair excess charged amount," which shall be the 
amount, ifany, by which treatment revenue from treatments provided by all ofthe governing 
entity's chronic dialysis clinics exceeds the fair treatment payment amount. 
(B) The governing entity or its chronic dialysis clinics shall, on a pro rata basis based on the 
amounts paid and reasonably estimated to be paid, as those amounts are included in treatment 
revenue, issue rebates to payers (other than Medicare or other federal, state, county, city, or 
local government payers) in amounts that total the unfair excess charged amount. 
(C) The governing entity or chronic dialysis clinic shall issue any rebates required by this 
section no less than 90 days and no more than 210 days after the end ofits fiscal year to which 
the rebate relates. 
(D) Where, in any fiscal year, the rebate the governing entity or chronic dialysis clinic must 
issue to a single payer is less than twenty dollars ($20), the governing entity or chronic dialysis 
clinic shall not issue that rebate, and shall provide to other payers in accordance with 
subparagraph (B) the total amount ofrebates not issued pursuant to this subparagraph. 
(E) For each fiscal year starting on or after January 1, 2020, any rebate issued to a payer shall 
be issued together with interest thereon at the rate ofinterest specified in subdivision (b) of 
Section 3289 ofthe Civil Code, which shall accrue.from the date ofpayment by the payer. 
(3) For each fiscal year starting on or after January 1, 2019, a governing entity shall maintain 
andprovide to the department, on a form and schedule prescribed by the department, a report of 
all rebates issued under paragraph (2), including a description ofeach instance during the 
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period covered by the submission when the rebate required under paragraph (2) was not timely 
issued in full, and the reasons and circumstances therefor. The chiefexecutive officer or 
principal officer ofthe governing entity shall certify under penalty ofperjury that he or she is 
satisfied, after review, that all information submitted to the department under this paragraph is 
accurate and complete. 
(4) In the event a governing entity or its chronic dialysis clinic is required to issue a rebate 
under this section, no later than 210 days after the end ofits fiscal year the governing entity 
shall pay a penalty to the department in an amount equal to five percent ofthe unfair excess 
charged amount, provided that the penalty shall not exceed one hundred thousand dollars 
($100,000). Penalties collected pursuant to this paragraph shall be used by the department to 
implement and enforce laws governing chronic dialysis clinics. 
(5) Ifa chronic dialysis clinic or governing entity disputes a determination by the department to 
assess a penalty pursuant to this subdivision or subdivision (b), or the amount ofan 
administrative penalty, the chronic dialysis clinic or governing entity may, within 10 working 
days, request a hearing pursuant to Section 131071. A chronic dialysis clinic or governing entity 
shall pay all administrative penalties when all appeals have been exhausted and the 
department's position has been upheld. 
(6) Ifa governing entity or chronic dialysis clinic proves in any court action that application of 
this section to the chronic dialysis clinic or governing entity will, in any particular fiscal year, 
violate due process or effect a taking ofprivate property requiring just compensation under the 
Constitution ofthis State or the Constitution ofthe United States, the provision at issue shall 
apply to the governing entity or chronic dialysis clinic, except that as to the fiscal year in 
question the number "115" whenever it appears in the provision at issue shall be replaced by the 
lowest possible whole number such that application ofthe provision to the governing entity or 
chronic dialysis clinic will not violate due process or effect a taking ofprivate property requiring 
just compensation. In any civil action, the burden shall be on the governing entity or chronic 
dialysis clinic to propose a replacement number and to prove that replacing "115 '' with any 
whole number lower than the proposed replacement number would, for the fiscal year in 
question, violate due process or effect a taking ofprivate property requiring just compensation. 
(b) Compliance reporting by chronic dialysis clinics. 
(1) For each fiscal year starting on or after January 1, 2019, a governing entity shall maintain 
and submit to the department a report concerning the following information for all ofthe chronic 
dialysis clinics the governing entity owns or operates in California-
(A) the number oftreatments performed; 
(B) direct patient care services costs; 
(C) health care quality improvement costs; 
(D) treatment revenue, including the difference between amounts billed but not yet paid and 
estimated realizable revenue; 
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(E) the fair treatment payment amount; 
(F) the unfair excess charged amount; 
(G) the amount, ifany, ofeach payer's rebate, provided that any individual patient shall be 
identified using only a unique identifier that does not reveal the patient's name or identity; and 
(H) a list ofpayers to whom no rebate was issued pursuant to subparagraph (D) ofparagraph 
(2) ofsubdivision (a) and the amount not issued, provided that any individual patient shall be 
identified using only a unique identifier that does not reveal the patient's name or identity. 
(2) The information required to be maintained and the report required to be submitted by this 
subdivision shall each be independently audited by a certified public accountant in accordance 
with the standards ofthe Accounting Standards Board ofthe American Institute ofCertified 
Public Accountants, and shall include the opinion ofthat certified public accountant as to 
whether the information contained in the report fully and accurately describes, in accordance 
with generally accepted accounting principles in the United States, the information required to 
be reported under paragraph (1). 
(3) The governing entity shall annually submit the report required by this subdivision to the 
department on a schedule, in a format, and on a form prescribed by the department, provided 
that the governing entity shall submit the information no later than 210 days after the end ofits 
fiscal year. The chiefexecutive officer or other principal officer ofthe governing entity shall 
certify under penalty ofperjury that he or she is satisfied, after review, that the report submitted 
to the department under paragraph (1) is accurate and complete. 
(4) In the event the department determines that a chronic dialysis clinic or governing entity 
failed to maintain the information or timely submit a report required under paragraph (1) ofthis 
subdivision or paragraph (3) ofsubdivision (a), or that the amounts or percentages reported by 
the chronic dialysis clinic or governing entity under paragraph (1) ofthis subdivision were 
inaccurate or incomplete, or that any failure by a chronic dialysis clinic or governing entity to 
timely issue in full a rebate required by subdivision (a) was not substantially justified, the 
department shall assess a penalty against the chronic dialysis clinic or governing entity not to 
exceed one hundred thousand dollars ($100,000). The department shall determine the amount of 
the penalty based on the severity ofthe violation, the materiality ofthe inaccuracy or omitted 
information, and the strength ofthe explanation, ifany, for the violation. Penalties collected 
pursuant to this paragraph shall be used by the department to implement and enforce laws 
governing chronic dialysis clinics. 
(c) Definitions. 
For purposes ofthis section: 
(1) "Direct patient care services costs" means those costs directly associated with operating a 
chronic dialysis clinic in California andproviding care to patients in California. Direct patient 
care services costs shall include, regardless ofthe location where each patient undergoes 
dialysis, only (i) salaries, wages, and benefits ofnon-managerial chronic dialysis clinic staff, 
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including all clinic personnel who furnish direct care to dialysis patients, regardless ofwhether 
the salaries, wages, or benefits are paid directly by the chronic dialysis clinic or indirectly 
through an arrangement with an affiliated or unaffiliated third party, including but not limited to 
a governing entity, an independent staffing agency, a physician group, or a joint venture between 
a chronic dialysis clinic and a physician group; (ii) stafftraining and development; (iii) 
pharmaceuticals and medical supplies; (iv) facility costs, including rent, maintenance, and 
utilities; (v) laboratory testing; and (vi) depreciation and amortization ofbuildings, leasehold 
improvements, patient supplies, equipment, and information systems. For purposes ofthis 
section, "non-managerial chronic dialysis clinic staff" includes all clinic personnel who furnish 
direct care to dialysis patients, including nurses, technicians and trainees, social workers, 
registered dietitians, and non-managerial administrative staff, but excludes managerial staff 
such as facility administrators. Categories ofdirect patient care services costs may be further 
prescribed by the department through regulation. 
(2) "Governing entity" means a person, firm, association, partnership, corporation, or other 
entity that owns or operates a chronic dialysis clinic for which a license has been issued, without 
respect to whether the person or entity itselfdirectly holds that license. 
(3) "Health care quality improvement costs" means costs, other than direct patient care services 
costs, that are related to the provision ofcare to chronic dialysis patients and that are actually 
expended for goods or services in California that are required to maintain, access or exchange 
electronic health information, to support health information technologies, to train non­
managerial chronic dialysis clinic staffengaged in direct patient care, and to provide patient­
centered education and counseling. Additional costs may be identified by the department through 
regulation, provided that such costs are actually spent on services offered at the chronic dialysis 
clinic to chronic dialysis patients and are spent on activities that are designed to improve health 
quality and to increase the likelihood ofdesired health outcomes in ways that are capable of 
being objectively measured and ofproducing verifiable results and achievements. 
(4) "Payer" means the person or persons who paid or are financially responsible for payments 
for a treatment provided to a particular patient, and may include the patient or other individuals, 
primary insurers, secondary insurers, and other entities, including Medicare and any other 
federal, state, county, city, or other local government payer. 
(5) "Treatment" means each instance when the chronic dialysis clinic provides services to a 
patient. 
(6) "Treatment revenue" for a particular fiscal year means all amounts actually received and 
estimated realizable revenue for treatments provided in that fiscal year. Estimated realizable 
revenue shall be calculated in accordance with generally accepted accounting principles, and 
shall be a reasonable estimate based on (i) contractual terms for patients covered under 
commercial healthcare plans with which the governing entity or clinics have formal agreements; 
(ii) revenue from Medicare, Medicaid, and Medi-Cal based on rates set by statute or regulation, 
and estimates ofamounts ultimately collectible from government payers, commercial healthcare 
plan secondary coverage, patients, and other payers; and (iii) historical collection experience. 
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SEC. 7. Section 1226.8 is added to the Health and Safety Code, to read: 
1226.8 (a) A chronic dialysis clinic shall not discriminate with respect to offering or providing 
care, and shall not refuse to offer or provide care, to patients on the basis ofthe payer for 
treatment provided to a patient, including but not limited to on the basis that the payer is a 
patient, private payer or insurer, Medi-Cal, Medicaid, or Medicare. 
(b) A chronic dialysis clinic shall not terminate, abridge, modify, or fail to perform under any 
agreement to provide services to patients covered by Medi-Cal, Medicaid, or Medicare on the 
basis ofrequirements imposed by this chapter. 
SEC. 8. Section 1266.3 is added to the Health and Safety Code, to read: 
1266. 3. It is the intent ofthe People that California taxpayers not be financially responsible for 
implementation and enforcement ofthe Kidney Dialysis Patient Protection Act. In order to 
effectuate that intent, when calculating, assessing, and collecting fees imposed on chronic 
dialysis clinics pursuant to Section 1266, the department shall take into account all costs 
associated with implementing and enforcing Sections 1226.4, 1226. 7, 1226.8, 1240.1, or 1240.2. 
SEC. 9. Section 1228 of the Health and Safety Code is amended to read: 
1228. (a) Except as provided in subdivision (c), every clinic for which a license or special 
permit has been issued shall be periodically inspected. The Except as provided in Section 1226.4, 
the frequency of inspections shall depend upon the type and complexity of the clinic or special 
service to be inspected. Inspections shall be conducted no less often than once every three years 
and as often as necessary to ensure the quality of care being provided. 
(b) (1) During inspections, representatives of the department shall offer any advice and 
assistance to the clinic as they deem appropriate. The department may contract with local health 
departments for the assumption of any of the department's responsibilities under this chapter. In 
exercising this authority, the local health department shall conform to the requirements of this 
chapter and to the rules, regulations, and standards of the department. 
(2) The department shall reimburse local health departments for services performed pursuant to 
this section, and these payments shall not exceed actual cost. Reports of each inspection shall be 
prepared by the representative conducting it upon forms prepared and furnished by the 
department and filed with the department. 
(c) This section shall not apply to any of the following: 
(1) A rural health clinic. 
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(2) A primary care clinic accredited by the Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO), the Accreditation Association for Ambulatory Health Care (AAAHC), 
or any other accrediting organization recognized by the department. 
(3) An ambulatory surgical center. 
(4) An end stage renal disease facility. 
A comprehensive outpatient rehabilitation facility that is certified to participate either in the 
Medicare program under Title XVIII (42 U.S.C. Sec. 1395 et seq.) of the federal Social Security 
Act, or the medicaid program under Title XIX (42 U.S.C. Sec. 1396 et seq.) of the federal Social 
Security Act, or both. 
(d) Notwithstanding paragraph (2) of subdivision ( c ), the department shall retain the authority to 
inspect a primary care clinic pursuant to Section 1227, or as necessary to ensure the quality of 
care being provided. 
SEC. 10. Nothing in this act is intended to affect health facilities licensed pursuant to 
subdivision (a), (b), or (f) of Section 1250 of the Health and Safety Code. 
SEC. 11. The State Department of Public Health shall issue regulations necessary to implement 
this act no later than 180 days following its effective date. 
SEC. 12. Pursuant to subdivision ( c) of Section 10 of Article II of the California Constitution, 
this Act may be amended either by a subsequent measure submitted to a vote of the people at a 
statewide election; or by a statute validly passed by the Legislature and signed by the Governor, 
but only to further the purposes of the Act. 
SEC. 13. The provisions of this act are severable. If any provision of this act or its application is 
held invalid, that invalidity shall not affect other provisions or applications that can be given 
effect without the invalid provision or application. 
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The Attorney General of California has prepared the following title and summary of the chief 
purpose and points of the proposed measure: 
AUTHORIZES STATE REGULATION OF KIDNEY DIALYSIS CLINICS.  
ESTABLISHES MINIMUM STAFFING REQUIREMENTS AND LIMITS CHARGES 
FOR PATIENT CARE.  INITIATIVE STATUTE.  Establishes minimum staffing 
requirements for nurses, technicians, and other staff at outpatient kidney dialysis clinics and sets 
minimum transition time between patients.  Limits amounts clinics may charge for patient care 
and imposes penalties for excessive charges.  Requires annual inspections and reporting to the 
state regarding clinic costs, patient charges, revenue, staffing ratios, and transition times between 
patients.  Authorizes investigations and imposes fines for violations.  Prohibits clinics from 
discriminating against patients based on the source of payment for care.  Summary of estimate by 
Legislative Analyst and Director of Finance of fiscal impact on state and local government:  
State administrative costs of around $10 million annually to be covered by increases in 
license fees on chronic dialysis clinics.  State and local government savings associated with 
reduced government employee and retiree health benefits spending on dialysis treatment, 
potentially up to tens of millions of dollars annually.  Net state government costs for    





FOR IMMEDIATE RELEASE  
October 13, 2017 
CONTACT:  
Jesse Melgar or Sam Mahood 
(916) 653-6575 
 
Proposed Initiative Enters Circulation 
Authorizes State Regulation of Kidney Dialysis Clinics. Establishes Minimum 
Staffing Requirements and Limits Charges for Patient Care. Initiative Statute. 
 
SACRAMENTO – Secretary of State Alex Padilla announced the proponent of a new initiative 
was cleared to begin collecting petition signatures today. 
 
The Attorney General prepares the legal title and summary that is required to appear on initiative 
petitions. When the official language is complete, the Attorney General forwards it to the 
proponent and to the Secretary of State, and the initiative may be circulated for signatures. The 
Secretary of State then provides calendar deadlines to the proponent and to county elections 
officials. The Attorney General’s official title and summary for the measure is as follows: 
 
AUTHORIZES STATE REGULATION OF KIDNEY DIALYSIS CLINICS. 
ESTABLISHES MINIMUM STAFFING REQUIREMENTS AND LIMITS 
CHARGES FOR PATIENT CARE. INITIATIVE STATUTE. Establishes 
minimum staffing requirements for nurses, technicians, and other staff at outpatient 
kidney dialysis clinics and sets minimum transition time between patients. Limits 
amounts clinics may charge for patient care and imposes penalties for excessive 
charges. Requires annual inspections and reporting to the state regarding clinic costs, 
patient charges, revenue, staffing ratios, and transition times between patients. 
Authorizes investigations and imposes fines for violations. Prohibits clinics from 
discriminating against patients based on the source of payment for care. Summary of 
estimate by Legislative Analyst and Director of Finance of fiscal impact on state and 
local government: State administrative costs of around $10 million annually to be 
covered by increases in license fees on chronic dialysis clinics. State and local 
government savings associated with reduced government employee and retiree 
health benefits spending on dialysis treatment, potentially up to tens of millions 
of dollars annually. Net state government costs for Medi-Cal, potentially in the 
low tens of millions of dollars annually in the long run. (17-0015.) 
 
The Secretary of State’s tracking number for this measure is 1811 and the Attorney General’s 
tracking number is 17-0015.  
 
The proponent of the measure, BJ Chisholm, must collect the signatures of 365,880 registered 
voters (five percent of the total votes cast for Governor in the November 2014 general election) 
in order to qualify it for the ballot. The proponent has 180 days to circulate petitions for the 
measure, meaning the signatures must be submitted to county elections officials no later than 
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Hon. Xavier Becerra 
Attorney General 
1300 I Street, 1 7th Floor 
Sacramento, California 95814 
Attention: Ms. Ashley Johansson 
Initiative Coordinator 
Dear Attorney General Becerra: 
Pursuant to Elections Code Section 9005, we have reviewed the proposed statutory initiative 
regarding staffing and pricing requirements for kidney dialysis providers (A.G. File No. 17-0015 
Amendment No. 1). 
BACKGROUND 
Chronic Dialysis Clinics 
End Stage Renal Disease (ESRD) Is the Final Stage ofChronic Kidney Disease. Patients 
suffering from ESRD, the fifth and final stage of kidney disease, must receive kidney dialysis (or 
a kidney transplant) to survive. Kidney dialysis artificially mimics what healthy kidneys do­
filtering out waste and toxins from the blood supply, either outside the body (hemodialysis) or 
inside the body (peritoneal dialysis). Peritoneal dialysis is typically conducted every day at the 
patient's home, whereas hemodialysis is typically administered at a clinic three times per week 
with each treatment lasting between three and four hours. 
Many ESRD Patients Treated at Chronic Dialysis Clinics (CDCs). Although ESRD patients 
can receive hemodialysis treatments at hospitals or in their own homes, many receive treatments 
at CDCs. In California, about 650 CDCs serve more than 66,000 ESRD patients. While CDCs 
are sometimes owned and operated by private nonprofit or public entities, two private for-profit 
entities-DaVita Healthcare Partners and Fresenius Medical Care-and their CDCs treat the vast 
majority of ESRD patients in California. 
Department ofPublic Health (DPH) Licenses and Inspects CDCs. DPH is responsible for 
licensing CDCs and conducting federal certification surveys for the Centers for Medicare and 
Medicaid Services (CMS). (While a license is issued to a CDC, the CDC itself may be owned or 
operated by a person, corporation, or other entity-referred to as a "governing entity" in this 
measure.) Through the federal certification process, DPH conducts inspections of each CDC 
about once every three years. DPH has not promulgated regulations for CDCs and currently 
follows federal certification standards for state licensing activities. It lacks the authority to 
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impose penalties on CDCs that fail to comply with certification standards. DPH is also 
responsible for certifying hemodialysis technicians who work with nurses to carry out 
hemodialysis treatments, including inserting needles to draw and replace blood and monitoring 
patients' vital signs. 
State Does Not Set Minimum Staffing Requirements. Currently, there are no federal or state 
minimum staffing requirements for CDCs, though federal regulations require an "adequate 
number" of qualified personnel (including direct care staff such as registered nurses) be present 
to maintain "appropriate" patient-to-staff ratios. 
State Follows Federal Guidance on Patient Transitions. Through its inspections of CDCs, 
DPH monitors compliance with recent CMS requirements about patient transitions (time 
between patients) at dialysis stations. CMS based the new requirements on a recommendation 
from the federal Centers for Disease Control and Prevention that to avoid cross contamination, a 
patient must have completely vacated a dialysis treatment station before the station is cleaned, 
disinfected, and prepared for the next patient. There are currently no state or federal rules 
specifying a minimum amount of time for transitions. 
CDCs Receive Compensation for Treatment From Various Payers. CD Cs receive payments 
for their services from patients and third-party payers. Third-party payers pay CDCs (the second 
party) for services delivered to patients (the first party). Below, we describe the third-party 
payers that account for the greatest volume of patients treated and amount of revenues received 
by CDCs. 
Government Programs 
Federal, state, and local government programs provide health care benefits to certain eligible 
populations. The two largest government programs for outpatient dialysis services in terms of 
patient volume and spending are Medicare and Medi-Cal, as described below. 
Medicare. This is the federally funded program that provides coverage to most individuals 65 
and older and certain younger persons with disabilities. Individuals with ESRD who need regular 
dialysis are eligible for Medicare coverage at any age if they, their spouse, or (if a dependent 
child) either of their parents meet certain work requirements. Medicare coverage for individuals 
with ESRD typically starts three months after dialysis begins. During this three-month "waiting 
period," an individual's other health insurance coverage-such as an employer group health plan 
or Medicaid-pays for the individual's dialysis. Once Medicare coverage starts, Medicare 
becomes the primary payer for dialysis except for individuals covered under an employer or 
union group health plan. (We discuss this exception in the commercial health insurers section 
below.) Medicare is the primary payer for the majority of patients receiving treatment at CDCs. 
Medi-Cal. In California, the federal-state Medicaid program, known as Medi-Cal, provides 
health care services to low-income Californians. The costs of the Medicaid program are 
generally shared between states and the federal government, and the percentage of Medi-Cal 
costs paid by the federal government varies depending on the enrollee and/or service. For Medi­
Cal beneficiaries with ESRD who are also eligible for Medicare-dual eligibles-Medicare is 
the primary payer for dialysis (after the three-month waiting period) and Medi-Cal is the 
secondary payer. Medicare covers 80 percent of the costs of outpatient dialysis services for dual 
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eligibles, and Medi-Cal covers the remaining 20 percent. Medi-Cal also covers any Medicare 
premiums, deductibles, or other costs that otherwise would be paid by the dual eligible. For 
Medi-Cal beneficiaries with ESRD who are not eligible for Medicare-non-dual eligibles­
Medi-Cal is the sole payer for dialysis. 
Medi-Cal Delivery Systems. Medi-Cal provides health care services through two main 
delivery systems: fee-for-service (FFS) and managed care. In the FFS system, a health care 
provider receives an individual payment for each medical service delivered to a beneficiary. 
Most dual eligibles receive dialysis through the Medi-Cal FFS system. In the managed care 
system, Medi-Cal generally contracts with managed care plans to provide health care for 
beneficiaries enrolled in these plans. Managed care enrollees may obtain services from 
providers-including CDCs-that accept payments from the plans. The plans are paid a 
predetermined amount per enrollee, per month (known as a capitation payment) regardless of the 
number of services each enrollee actually receives. Some Medi-Cal managed care plans are 
administered by government entities such as counties, whereas other plans are operated by 
commercial health insurers that contract with Medi-Cal. Most non-dual eligibles receive dialysis 
through the Medi-Cal managed care system. 
Major Risk Medical Insurance Program (MRMIP). The MRMIP provides health insurance 
coverage to individuals who, prior to the Patient Protection and Affordable Care Act (ACA), 
could not obtain coverage or were charged unaffordable premiums in the individual health 
insurance market because of their preexisting conditions. Given the ACA's prohibition on health 
plans denying coverage to individuals based on preexisting conditions, most MRMIP enrollees 
can now obtain other coverage. A few individuals with ESRD, however, remain enrolled in 
MRMIP because, for example, they are ineligible for other coverage based on their immigration 
status. 
Commercial Health Insurers 
Commercial health insurers provide coverage to members of employer groups, organizations, 
or individuals who purchase health insurance. These insurers receive a premium in exchange for 
covering an agreed-upon set of health care services. 
Commercial Health Insurers and Medicare. During Medicare's three-month waiting period, 
an individual's other health insurance coverage pays for dialysis. After the waiting period, if an 
individual is covered under an employer or union group health plan, the plan must continue to 
pay for dialysis as the primary payer (with Medicare as the secondary payer) for another 
30 months. These additional 30 months are referred to as a "coordination period." After this 
coordination period, Medicare becomes the primary payer and the employer or union group 
health plan becomes the secondary payer. 
Health Benefits/or State and Local Government Employees and Retirees. The state, 
California's two public university systems, and many local govermnents in California provide 
health benefits for their employees and related family members and for some of their retired 
workers. Typically, state and local governments contract with commercial health insurers to 
cover health care services, Together, state and local governments pay tens of billions of dollars 
for employee and retiree health benefits each year. 
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Rates Paid by Commercial Health Insurers Significantly Exceed Rates Paid by 
Government Programs 
Government Program Rates Are Primarily Set Through Medicare. Outpatient dialysis rates 
for government programs are primarily set by CMS in Medicare. Dialysis providers cannot 
directly negotiate higher rates from CMS. Because Medi-Cal FFS rates for outpatient dialysis 
provided to dual eligibles are based on Medicare rates, these rates are also not subject to 
negotiation. CDCs and governing entities can, however, negotiate higher rates from Medi-Cal 
managed care plans serving non-dual eligibles. In many cases, Medi-Cal managed care plans 
base their rates on Medi-Cal FFS rates (and thus on Medicare rates), but in some cases will pay 
providers higher rates depending on a provider's availability in a given service area in order to 
maintain access to services needed for their beneficiaries. 
Commercial Rates Are Negotiated Between Insurers and Providers. Outpatient dialysis 
rates for commercial health insurers are set through negotiations between the commercial health 
insurers and CDCs' governing entities. Depending on the governing entity's market power, the 
entity can potentially negotiate rates that are much higher than the Medicare rates. 
Relative to Patients Covered, Commercial Health Insurers Represent a Disproportionate 
Share ofCDC Revenue. For example, based on financial information from one major governing 
entity in the state, commercial health insurers account for about one-tenth of this particular 
governing entity's patients and treatments, but generate about one-third of the governing entity's 
total annual revenues. (CDCs receive a significant portion of their revenues during the 30-month 
coordination period when an employer or union health plan is the primary payer for dialysis 
services and Medicare is the secondary payer.) Government programs, on the other hand, 
account for about nine-tenths of the governing entity's patients and treatments, but generate only 
two-thirds of its total annual revenues. We estimate that commercial health insurers, on average, 
pay multiple times what government programs pay for outpatient dialysis services. 
PROPOSAL 
Places New Operational Requirements on CDCs 
Sets Minimum Direct Care Staffing Requirements. This measure requires CDCs to have at 
least one registered nurse for every eight patients and at least one certified hemodialysis 
technician for every three patients. The measure also requires CDCs to ensure the patient 
caseloads of a full-time equivalent social worker or dietician does not exceed 75. Staffing 
requirements would take effect March 31, 2019. 
Establishes Minimum Transition Times. This measure would require that the transition time 
between patients at a dialysis treatment station be at least 45 minutes, unless DPH can 
demonstrate with clinical evidence why a shorter amount of time would be sufficient. 
Requirements about minimum transition times would take effect March 31, 2019. 
Requires Annual Inspections by DPH. This measure requires DPH to conduct inspections of 
each CDC at least annually, and as often as necessary, to ensure compliance with hygiene and 
sanitation protocols, compliance with the staffing and transition time requirements of this 
measure, and adequacy of the quality of patient care. 
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Requires Quarterly Reporting. This measure requires CDCs to provide information about 
actual staffing ratios and transition times to DPH at least four times per year, including: (1) the 
daily total number of hours and actual hours worked by nurses and hemodialysis technicians, 
(2) the daily total number of patients and actual hours they received direct care, (3) the daily 
average transition time for each dialysis station, and (4) the weekly number of full-time 
equivalent social workers and registered dieticians and their patient caseload numbers. The 
report must also include information about any instances in which the CDC was out of 
compliance with this measure and the reasons for noncompliance. 
Requires Timely Investigation ofComplaints. This measure requires DPH to investigate 
complaints about violations of this measure's provisions within 60 days and specifies that the 
complaints can come from a patient, a patient's family member, or an association of patients; an 
employee or association of employees; a vendor; or a contractor. If the investigation reveals that 
a CDC was in violation of the provisions, the measure requires DPH to assess an appropriate 
penalty (as specified below). 
Establishes Penalty Structure. This measure requires DPH to promulgate regulations about 
the criteria to be used to assess administrative penalties against CDCs that have violated 
provisions of this measure. It stipulates the criteria should include, at a minimum, consideration 
of patient risks, actual harm to patients, the severity of the violation, the CDC's history of 
compliance with regulations, whether it had any control over the violation, whether it willfully 
committed the violation, and whether it acted quickly to remedy a known violation. The measure 
allows DPH to assess administrative penalties (which a CDC may contest by requesting a 
hearing) as follows: 
• Up to $100,000 for major violations, 
• Up to $20,000 for intermediate violations, and 
• Up to $2,000 for minor violations. 
Beginning January 1, 2019, and up until DPH has promulgated its penalty regulations 
described above, DPH can assess penalties ofup to $100,000 for violations that put patients in 
immediate jeopardy of serious injury or death. 
Limits, in Effect, Prices Clinics May Charge Commercial Health Insurers 
Requires Rebates to Commercial Health Insurers When Total Revenues Exceed Specified 
Cap. Beginning in 2019, the measure requires each governing entity to annually calculate the 
amount by which total dialysis treatment revenues in all of its clinics exceed a cap equal to 
115 percent of certain specified costs for direct patient care plus certain specified costs related to 
treatment quality (such as health information technology or clinic staff training). The measure 
then requires the governing entity or its CDCs to annually distribute rebates that equal the 
amount by which total treatment revenues exceed the cap. The measure specifies that Medicare 
and other federal, state, or local government payers would not receive rebates, such that rebates 
would be primarily paid to commercial health insurers. There is some uncertainty as to whether 
commercial plans that contract with state and local governments to provide health benefits (such 
as plans that cover employees and retirees or Medi-Cal beneficiaries in the managed care 
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delivery system) would be eligible for rebates under the initiative. This is because the 
commercial plans are providing services on behalf of a government entity, but they are 
themselves private entities and are financially responsible for paying for the services. Whether 
these commercial plans would be eligible for rebates will depend on how the measure is 
implemented. Rebates would be allocated to each commercial health insurer proportional to the 
amount initially paid for dialysis treatment. By requiring rebates to in the event that total 
revenues exceed the cap, the measure would effectively limit the average rate CDCs and their 
governing entities may charge commercial health insurers. 
In the event that a governing entity or its CDCs are required to provide a rebate, the measure 
further requires the governing entity to pay interest on the rebate to the payer ( calculated from 
the date that the initial payment for treatment was made) and a penalty to DPH in the amount of 
5 percent of the amount of the rebates (up to a maximum of $100,000), the proceeds of which 
would go to fund DPH's costs to administer the functions required in the measure. 
Outlines Legal Process for Revenue Cap to Be Raised in Certain Circumstances. The 
measure envisions the possibility that a CDC or governing entity might bring a legal challenge 
against the measure's rebate provisions on the basis that, for a particular fiscal year, requiring the 
payment of rebates amounts to an unconstitutional taking of private property without due process 
or just compensation. In the event that such a challenge is successful, the measure requires that 
the rebate provisions would still apply, but only after the court replaces the measure's revenue 
cap with the lowest possible alternative revenue cap (a ratio of specified direct patient care and 
quality costs higher than 115 percent) that would not be unconstitutional. The measure places the 
burden on the challenging CDC or governing entity to propose the alternative revenue cap. 
Requires Annual Reporting. This measure requires governing entities to prepare annual 
reports relative to the rebate provisions and to submit them to DPH for each fiscal year starting 
on or after January 1, 2019. These reports are to list the number of treatments provided, the 
amount of direct care and quality improvement costs, the amount of the governing entity's 
revenue cap, the amount by which revenues exceeded the cap, and the amounts of rebates 
provided to various payers. The DPH may assess penalties ofup to $100,000 if a governing 
entity fails to maintain required reporting information, fails to submit reports in a timely manner, 
inaccurately reports information about treatment costs, or fails to justify why rebates were not 
issued in a timely manner. Any resulting penalty funds must be used by DPH for the 
implementation and enforcement of laws concerning CDCs. 
FISCAL EFFECTS 
State Agency Administrative Costs 
The measure imposes new administrative, regulatory, oversight, and workload 
responsibilities on DPH. Although the total cost to comply with these new duties is likely around 
$10 million annually, the measure requires DPH to adjust the annual license fee paid by CDCs, 
which is currently set at $3,407 per facility, to cover these costs. Some implementation and 
enforcement costs would be offset by penalties assessed on CDCs or their governing entities for 
failing to comply with reporting requirements, but the amount of this offset is unknown. 
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Fiscal Impact Depends on CDC's Response to Measure's Requirements 
Staffing Ratios and Transition Time Requirements Would Increase CDC Costs. While we 
do not have comprehensive data on current staffing levels or transition times at CDCs in 
California, it appears that many CDCs are not currently meeting staffing ratio and transition time 
requirements in the measure. For these entities, coming into compliance with the measure's 
requirements would involve hiring additional staff, expanding hours of operation, and acquiring 
additional treatment stations, which would increase these CDCs' operating costs. 
Various Potential Responses to Rebate Provisions. Based on our research into the 
operations of major dialysis governing entities, many CDCs and governing entities have 
revenues that exceed the measure's 115 percent revenue cap and, as such, we expect the rebate 
provisions in the measure would apply under existing revenue and cost structures. However, the 
effect of the measure on CDC operations-and ultimately on state and local government 
finances-would depend on how, if at all, CDCs change operations in response to the measure to 
avoid having to pay rebates. Some potential behavioral responses to the rebate provisions are: 
• Modify Revenue and Cost Structures. In order to avoid paying rebates (and the 
accompanying 5 percent penalty on the amount of rebates) CDCs and governing 
entities would likely modify their revenue and cost structures. For example, CDCs 
and governing entities could charge lower rates to commercial health insurers in order 
to bring total revenue below the cap. CDCs and governing entities could also modify 
their cost structures to increase the portion of their costs that count toward setting the 
revenue cap. For example, CDCs and governing entities could increase spending on 
direct services and specified quality improvement items while reducing overhead and 
management costs that are not counted toward determining the revenue cap. This 
would increase the revenue cap and the effective rates that could be charged to 
commercial health insurers without triggering rebates for those CDCs and governing 
entities. 
• Seek Adjustments to the Revenue Cap. In instances where CDCs believe they cannot 
achieve a reasonable return on their operations, they may choose to challenge the 
application of the rebate provisions in court. If such challenges proceed as the 
measure envisions, successful challenges could result in higher revenue caps for some 
CDCs in some years. 
• Cease Operations. Finally, reduced revenues under the rebate provisions would 
decrease incentives for CDCs and their governing entities to participate in the market. 
CD Cs and governing entities in some cases may decide to cease operations if reduced 
revenues under the rebate provisions do not provide sufficient inducement to remain 
in the market. 
Fiscal Impact of Various Behavioral Responses 
Potential Savings to State and Local Governments Providing Employee Health Coverage. 
Commercial health insurers that provide health benefits for state and local govermnent 
employees-if they are considered eligible under the measure-would likely pay lower rates for 
dialysis treatment, either through receiving rebates or by negotiating lower prices (since CDCs 
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and governing entities would have an incentive to negotiate rates low enough to avoid having to 
pay a penalty of 5 percent of the rebated amount). The extent to which commercial health 
insurers pay lower rates would depend on how CDCs and governing entities respond to the 
provisions of the measure. For example, reductions in commercial health insurer rates would be 
partially offset to the extent that CDCs and governing entities increase spending on direct 
services and quality improvements in order to comply with the measure's requirements. How 
much these lower rates might reduce health insurance premiums paid by state and local 
governments for their employees is uncertain. For example, commercial health plans that 
contract with the California Public Employees' Retirement System (CalPERS)-which provides 
health coverage to state employees, some local government employees, retirees, and their 
families-paid about $70 million for dialysis services in 2016 (for enrollees for which the 
CalPERS plan was the primary payer). We assume that there could be a significant reduction in 
these costs under the initiative. Some portion of these savings could be retained by the health 
plans, with the remainder of the savings passed on as reductions in employer health insurance 
premiums paid by state and local governments. Given these assumptions-as well as the number 
of commercial health insurers who provide health benefits for local government and school 
district employees that do not participate in CalPERS-we estimate that state and local 
governments could potentially save up to tens of millions of dollars under this initiative. 
Net State Government Costs for Medi-Cal. As discussed above, the initiative's staffing ratio 
and transition time requirements would increase operating costs for CDCs. Increased costs at 
CDCs could increase state costs in the Medi-Cal program, both in the short term and long term. 
In the short term, it is unclear to what extent, if at all, potential increases in CDC operating costs 
would ultimately be reflected in Medicare and Medi-Cal FFS rates. As noted previously, CDCs 
and governing entities do not directly negotiate rates with Medicare, and Medi-Cal FFS rates (for 
dual eligibles) are based on Medicare rates. Most non-dual eligibles with ESRD, however, 
receive dialysis through Medi-Cal managed care. CDCs with increased operating costs could 
charge higher rates to Medi-Cal managed care plans, and plans' higher costs could ultimately be 
reflected in higher capitation payments from the state. Non-dual eligibles with ESRD, however, 
are a small population within Medi-Cal managed care. Commercial Medi-Cal managed care 
plans' higher costs could also be offset somewhat-either through receiving rebates or 
negotiating lower prices with providers-if such plans are considered eligible for rebates under 
this measure. To the extent such commercial plans do receive rebates or negotiate lower prices, 
there could be modest offsetting savings to the Medi-Cal program. Over the long term, increased 
costs for CDCs could put upward pressure on Medicare rates. To the extent that Medicare rates 
are adjusted upward to reflect increased costs, the state would eventually have increased costs for 
dual eligibles with ESRD in the Medi-Cal FFS delivery system. We estimate that total net state 
costs could be in the low tens of millions of dollars annually in the long run. 
Highly Uncertain Fiscal Effects From Potential Changes in Quality and Availability of 
Treatment. Depending on how CDCs respond to the measure, the quality and availability of 
dialysis treatment in California could change, with potential fiscal effects on state and local 
governments. For example, it is possible that the staffing and transition time requirements 
imposed by the measure could improve the overall quality of dialysis treatment in the state and 
result in an improvement in health outcomes for dialysis patients, such as reduced 
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hospitalizations. To the extent that the requirements of the measure reduce dialysis patients' need 
for health care services beyond dialysis treatment, state and local government costs related to 
health care (including costs to provide health care to employees and retirees or costs to fund 
Medi-Cal and other state programs that provide health coverage for certain California residents) 
could be reduced. On the other hand, if CDCs collectively reduce operations in the state as a 
result of the measure's requirements, the availability of outpatient dialysis services might be 
reduced. In that case, patients might seek dialysis treatment in more expensive inpatient settings 
or could require additional treatment related to not having timely access to dialysis treatment. 
This could potentially result in higher state and local government costs related to health care. 
Whether these effects would ultimately materialize or what their potential magnitude would be 
are highly uncertain. 
Summary of Fiscal Effects 
We estimate that the measure would have the following major fiscal impacts: 
• State administrative costs of around $10 million annually to be covered by increases 
in license fees on chronic dialysis clinics. 
• State and local government savings associated with reduced government employee 
and retiree health benefits spending on dialysis treatment, potentially up to tens of 
millions of dollars annually. 
• Net state government costs for Medi-Cal, potentially in the low tens of millions of 
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